Breast Cancer
Showing NaN - NaN of 215
Breast Cancer Trial in Nashville (diffusion-weighted magnetic resonance imaging, dynamic contrast-enhanced magnetic resonance
Active, not recruiting
- Breast Cancer
- diffusion-weighted magnetic resonance imaging
- +2 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Nov 22, 2021
Breast Cancer Trial in United States (Ixabepilone, Cyclophosphamide)
Completed
- Breast Cancer
-
Aventura, Florida
- +19 more
Nov 18, 2021
Breast Cancer, Breast Tumors Trial in United States (Bevacizumab, Anastrozole, Fulvestrant)
Completed
- Breast Cancer
- Breast Neoplasms
- Bevacizumab
- +2 more
-
Fort Myers, Florida
- +10 more
Nov 16, 2021
Breast Cancer Trial in United States (Trastuzumab, Oxaliplatin)
Completed
- Breast Cancer
-
Bowling Green, Kentucky
- +6 more
Oct 13, 2021
Breast Cancer Trial in United States (systemic chemo, axillary lymph node dissection, neoadjuvant therapy)
Active, not recruiting
- Breast Cancer
- systemic chemotherapy
- +5 more
-
Mobile, Alabama
- +323 more
Aug 16, 2021
Breast Cancer, Urothelial Carcinoma Trial in Worldwide (Trastuzumab deruxtecan, Nivolumab)
Active, not recruiting
- Breast Cancer
- Urothelial Carcinoma
- Trastuzumab deruxtecan
- Nivolumab
-
Santa Monica, California
- +28 more
Aug 11, 2021
Breast Cancer Trial in Worldwide (Tesetaxel and Capecitabine, Capecitabine)
Terminated
- Breast Cancer
- Tesetaxel and Capecitabine
- Capecitabine
-
Chandler, Arizona
- +206 more
Jul 26, 2021
Breast Cancer Trial in United States (Low dose FRa vaccine, Cyclophosphamide, High dose FRa vaccine)
Completed
- Breast Cancer
- Low dose FRα vaccine
- +2 more
-
Tampa, Florida
- +10 more
Jul 15, 2021
Investigation of Genetic Determinants of Capecitabine Toxicity
Active, not recruiting
- Breast Cancer
- Side-effect questionnaires
- research blood samples
-
Birmingham, Alabama
- +12 more
Jun 22, 2021
Advanced Solid Tumors, Ovarian Cancer, Breast Cancer Trial in Canada, France, United States (SY-1365 (Part 1), Carboplatin,
Terminated
- Advanced Solid Tumors
- +2 more
- SY-1365 (Part 1)
- +5 more
-
Birmingham, Alabama
- +19 more
Mar 5, 2021
Breast Cancer Trial in Worldwide (Capecitabine, Exemestane, Everolimus)
NBRST: Prospective Neo-adjuvant REGISTRY Trial
Completed
- Breast Cancer
- MammaPrint 70-gene expression profile
- BluePrint 80 gene expression profile
-
Glendale, Arizona
- +75 more
Jan 14, 2021